Literature DB >> 31617733

Attenuated pulmonary fibrosis in sialidase-3 knockout (Neu3-/-) mice.

Tejas R Karhadkar1, Wensheng Chen1, Richard H Gomer1.   

Abstract

Pulmonary fibrosis involves the formation of inappropriate scar tissue in the lungs, but what drives fibrosis is unclear. Sialidases (also called neuraminidases) cleave terminal sialic acids from glycoconjugates. In humans and mice, pulmonary fibrosis is associated with desialylation of glycoconjugates and upregulation of sialidases. Of the four mammalian sialidases, we previously detected only NEU3 in the bronchoalveolar lavage fluid from mice with bleomycin-induced pulmonary fibrosis. In this report, we show that NEU3 upregulates extracellular accumulation of the profibrotic cytokines IL-6 and IL-1β, and IL-6 upregulates NEU3 in human peripheral blood mononuclear cells, suggesting that NEU3 may be part of a positive feedback loop potentiating fibrosis. To further elucidate the role of NEU3 in fibrosis, we used bleomycin to induce lung fibrosis in wild-type C57BL/6 and Neu3-/- mice. At 21 days after bleomycin, compared with male and female C57BL/6 mice, male and female Neu3-/- mice had significantly less inflammation, less upregulation of other sialidases and the profibrotic cytokine active transforming growth factor β1, and less fibrosis in the lungs. Our results suggest that NEU3 participates in fibrosis and that NEU3 could be a target to develop treatments for fibrosis.

Entities:  

Keywords:  bleomycin mouse model; idiopathic pulmonary fibrosis; sialidase NEU3; therapeutics

Mesh:

Substances:

Year:  2019        PMID: 31617733      PMCID: PMC6985870          DOI: 10.1152/ajplung.00275.2019

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  85 in total

Review 1.  Desialylation of surface receptors as a new dimension in cell signaling.

Authors:  A V Pshezhetsky; L I Ashmarina
Journal:  Biochemistry (Mosc)       Date:  2013-07       Impact factor: 2.487

2.  Human airway epithelia express catalytically active NEU3 sialidase.

Authors:  Erik P Lillehoj; Sang Won Hyun; Chiguang Feng; Lei Zhang; Anguo Liu; Wei Guang; Chinh Nguyen; Wenji Sun; Irina G Luzina; Tonya J Webb; Sergei P Atamas; Antonino Passaniti; William S Twaddell; Adam C Puché; Lai-Xi Wang; Alan S Cross; Simeon E Goldblum
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-03-21       Impact factor: 5.464

Review 3.  Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Authors:  Inessa Schwab; Falk Nimmerjahn
Journal:  Nat Rev Immunol       Date:  2013-02-15       Impact factor: 53.106

Review 4.  Mammalian sialidases: physiological and pathological roles in cellular functions.

Authors:  Taeko Miyagi; Kazunori Yamaguchi
Journal:  Glycobiology       Date:  2012-02-28       Impact factor: 4.313

Review 5.  Review Series--Inflammation & Fibrosis. Fibrocytes and fibrosis.

Authors:  R Bucala
Journal:  QJM       Date:  2012-06

Review 6.  Pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Paul J Wolters; Harold R Collard; Kirk D Jones
Journal:  Annu Rev Pathol       Date:  2013-09-13       Impact factor: 23.472

7.  Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice.

Authors:  Y Taooka; A Maeda; K Hiyama; S Ishioka; M Yamakido
Journal:  Am J Respir Crit Care Med       Date:  1997-07       Impact factor: 21.405

Review 8.  Animal models of fibrotic lung disease.

Authors:  Bethany B Moore; William E Lawson; Tim D Oury; Thomas H Sisson; Krishnan Raghavendran; Cory M Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

9.  The pathogenesis of bleomycin-induced pulmonary fibrosis in mice.

Authors:  I Y Adamson; D H Bowden
Journal:  Am J Pathol       Date:  1974-11       Impact factor: 4.307

Review 10.  The IL-1 cytokine family and its role in inflammation and fibrosis in the lung.

Authors:  L A Borthwick
Journal:  Semin Immunopathol       Date:  2016-03-21       Impact factor: 9.623

View more
  12 in total

1.  TGF-β1 increases sialidase 3 expression in human lung epithelial cells by decreasing its degradation and upregulating its translation.

Authors:  Wensheng Chen; Teresa M Lamb; Richard H Gomer
Journal:  Exp Lung Res       Date:  2020-02-26       Impact factor: 2.459

2.  Therapeutic Effect of Neuraminidase-1-Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis.

Authors:  Irina G Luzina; Erik P Lillehoj; Virginia Lockatell; Sang W Hyun; Katerina N Lugkey; Akihiro Imamura; Hideharu Ishida; Christopher W Cairo; Sergei P Atamas; Simeon E Goldblum
Journal:  J Pharmacol Exp Ther       Date:  2020-11-02       Impact factor: 4.030

3.  STING signaling activation inhibits HBV replication and attenuates the severity of liver injury and HBV-induced fibrosis.

Authors:  Yuqi Li; Minjing He; Ziyu Wang; Zhiyun Duan; Zhiwei Guo; Ziteng Wang; Ruijie Gong; Tianhao Chu; Jiabin Cai; Bo Gao
Journal:  Cell Mol Immunol       Date:  2021-11-22       Impact factor: 11.530

Review 4.  Sialidase NEU3 and its pathological significance.

Authors:  Taeko Miyagi; Koji Yamamoto
Journal:  Glycoconj J       Date:  2022-06-08       Impact factor: 3.009

5.  Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice.

Authors:  Tejas R Karhadkar; Darrell Pilling; Richard H Gomer
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

6.  A CD209 ligand and a sialidase inhibitor differentially modulate adipose tissue and liver macrophage populations and steatosis in mice on the Methionine and Choline-Deficient (MCD) diet.

Authors:  Darrell Pilling; Tejas R Karhadkar; Richard H Gomer
Journal:  PLoS One       Date:  2020-12-30       Impact factor: 3.240

7.  Defect in cytosolic Neu2 sialidase abrogates lipid metabolism and impairs muscle function in vivo.

Authors:  Mijung Oh; Dae-In Ha; Chaeyeon Son; Jeong Gu Kang; Heeyoun Hwang; Su Bin Moon; Minjeong Kim; Jihae Nam; Jung Soo Kim; Sang Yong Song; Yong-Sam Kim; Sangwoo Park; Jong Shin Yoo; Jeong-Heon Ko; Kyoungsook Park
Journal:  Sci Rep       Date:  2022-02-25       Impact factor: 4.996

8.  Inhibiting Sialidase-Induced TGF-β1 Activation Attenuates Pulmonary Fibrosis in Mice.

Authors:  Tejas R Karhadkar; Thomas D Meek; Richard H Gomer
Journal:  J Pharmacol Exp Ther       Date:  2020-11-03       Impact factor: 4.030

9.  Pulmonary fibrosis: something old, something new…still waiting for a breakthrough.

Authors:  Carol Feghali-Bostwick
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-08-05       Impact factor: 5.464

Review 10.  The Role of TGF-β Signaling Pathways in Cancer and Its Potential as a Therapeutic Target.

Authors:  Yun Yang; Wen-Long Ye; Ruo-Nan Zhang; Xiao-Shun He; Jing-Ru Wang; Yu-Xuan Liu; Yi Wang; Xue-Mei Yang; Yu-Juan Zhang; Wen-Juan Gan
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-22       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.